Having trouble viewing this email? View in your browser.

20 December 2016

Dear colleagues,

Researchers in Switzerland and Australia published a paper in PLOS where they question the validity of quantifying deaths due to antimicrobial resistance cited by the AMR report. They criticized that the authors failed to acknowledge the associated uncertainties regarding the incidence of infections, the prevalence of resistance and the attributable mortality. The authors conclude that detailed reliable data – comprehensive population-based surveillance data from low-, middle-, and high-income countries – is required to improve AMR control measures.

Season's greetings, your ESCMID communications editors


Check out our first clips with ECCMID 2017 keynote speakers

The keynote lectures at ECCMID 2017 in Vienna are presented by renowned speakers who will offer discourse on novel diagnostics and genetics approaches, strategies to fight antimicrobial resistance as well as insights into major challenges including hepatitis B, malaria or HIV. Listen to keynote speaker Gilbert Greub from the Institute of Microbiology at the CHUV hospital in Lausanne who will talk about the recent revolution in diagnostic bacteriology.

› Read more

CMI highlight: role of healthcare providers in tackling vaccine hesitancy

Ève Dubé from the National Health Institute of Quebec in a comment discusses a study describing discrepancies between GPs’ vaccination recommendations for their patients and practices for their own children published in CMI. Dubé concludes that it is of critical importance to identify providers who are vaccine-hesitant to understand the causes of their hesitancies and to develop tailored strategies if we wish to maintain vaccination programs successes. As within the population, vaccine hesitancy in healthcare providers is highly context-specific and varies between different vaccines, professions and in time. There are important gaps in our understanding of the complex mix of factors leading to vaccine hesitancy among healthcare providers, which are key to design effective targeted interventions. Read a Healio article about vaccine hesitancy citing the original paper as well as an expert comment by ESCMID's vaccines study group EVASG. And read Dubé's paper in CMI.

› Read more

Veterinary microbiology group publishes its first newsletter

ESCMID’s study group for veterinary microbiology ESGVM published its first newsletter. The topics include publications, presentations, educational activities, research projects as well as an outlook for activities at ECCMID 2017 in Vienna.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.